Left Atrial Volume Index: Relation to Long-Term Clinical Outcome in Type 2 Diabetes

J Am Coll Cardiol. 2013 Dec 24;62(25):2416-2421. doi: 10.1016/j.jacc.2013.08.1622. Epub 2013 Sep 24.

Abstract

Objectives: The study sought to determine the prognostic importance of left atrial (LA) dilation in patients with type 2 diabetes mellitus (T2DM) and no history of cardiovascular disease (CVD).

Background: T2DM is associated with the development of CVD, and morphological changes in the heart may appear before symptoms arise.

Methods: A total of 305 T2DM patients without known CVD referred to a diabetes clinic were included consecutively (age 58.6 ± 11.3 years, diabetes duration 2.0 [interquartile range: 0 to 6.0] years). Each patient underwent a comprehensive echocardiogram and a myocardial perfusion scintigraphy (MPS) at inclusion. Patients were divided according to left atrial volume index (LAVi) ≥32 ml/m(2). Patients were followed for median of 5.6 (interquartile range: 5.1 to 6.1) years for the occurrence of major cardiac events and death.

Results: LAVi ≥32 ml/m(2) was found in 105 patients (34%). During follow-up, 60 patients (20%) experienced the composite endpoint, of whom 28 (9%) died. Patients with LAVi ≥32 ml/m(2) had a significantly higher cardiac event rate and death rate (p < 0.001 and p = 0.002, respectively). Univariate predictors of the composite endpoint were age, hypertension, left ventricular diastolic function, E/e'septum-ratio and LAVi ≥32 ml/m(2); however, myocardial ischemia on MPS was not a predictor. When adjusting for age and hypertension, only LAVi ≥32 ml/m(2) was a predictor of the composite endpoint (hazard ratio: 1.82 [95% confidence interval: 1.08 to 3.07], p = 0.024).

Conclusions: Increased LAVi was an independent and incremental predictor of cardiovascular morbidity and mortality in T2DM patients with no history of CVD. (Presence of Macrovascular Disease in Type 2 Diabetes Mellitus; NCT00298844).

Keywords: CVD; LAVi; LV; MACE; MPS; SSS; T2DM; cardiovascular disease; clinical outcome; echocardiography; left atrial volume index; left ventricular; major cardiovascular event(s); myocardial perfusion scintigraphy; summed stress score; type 2 diabetes mellitus.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Atrial Function, Left / physiology*
  • Cardiac Volume / physiology*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetes Mellitus, Type 2 / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Single-Blind Method
  • Time Factors
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT00298844